Literature DB >> 33903248

Fitness selection of hyperfusogenic measles virus F proteins associated with neuropathogenic phenotypes.

Satoshi Ikegame1, Takao Hashiguchi2,3, Chuan-Tien Hung1, Kristina Dobrindt4, Kristen J Brennand4, Makoto Takeda5, Benhur Lee6.   

Abstract

Measles virus (MeV) is resurgent and caused >200,000 deaths in 2019. MeV infection can establish a chronic latent infection of the brain that can recrudesce months to years after recovery from the primary infection. Recrudescent MeV leads to fatal subacute sclerosing panencephalitis (SSPE) or measles inclusion body encephalitis (MIBE) as the virus spreads across multiple brain regions. Most clinical isolates of SSPE/MIBE strains show mutations in the fusion (F) gene that result in a hyperfusogenic phenotype in vitro and allow for efficient spread in primary human neurons. Wild-type MeV receptor-binding protein is indispensable for manifesting these mutant F phenotypes, even though neurons lack canonical MeV receptors (CD150/SLAMF1 or nectin-4). How such hyperfusogenic F mutants are selected and whether they confer a fitness advantage for efficient neuronal spread is unresolved. To better understand the fitness landscape that allows for the selection of such hyperfusogenic F mutants, we conducted a screen of ≥3.1 × 105 MeV-F point mutants in their genomic context. We rescued and amplified our genomic MeV-F mutant libraries in BSR-T7 cells under conditions in which MeV-F-T461I (a known SSPE mutant), but not wild-type MeV, can spread. We recovered known SSPE mutants but also characterized at least 15 hyperfusogenic F mutations with an SSPE phenotype. Structural mapping of these mutants onto the prefusion MeV-F trimer confirm and extend our understanding of the F regulatory domains in MeV-F. Our list of hyperfusogenic F mutants is a valuable resource for future studies into MeV neuropathogenesis and the regulation of paramyxovirus F.

Entities:  

Keywords:  Nipah virus; fusion; measles virus; mutagenesis; viral encephalitis

Mesh:

Substances:

Year:  2021        PMID: 33903248      PMCID: PMC8106313          DOI: 10.1073/pnas.2026027118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion.

Authors:  L Chen; J J Gorman; J McKimm-Breschkin; L J Lawrence; P A Tulloch; B J Smith; P M Colman; M C Lawrence
Journal:  Structure       Date:  2001-03-07       Impact factor: 5.006

2.  Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

Authors:  T Cathomen; H Y Naim; R Cattaneo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Subacute sclerosing panencephalitis is typically characterized by alterations in the fusion protein cytoplasmic domain of the persisting measles virus.

Authors:  A Schmid; P Spielhofer; R Cattaneo; K Baczko; V ter Meulen; M A Billeter
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

4.  Error-prone pcr-based mutagenesis strategy for rapidly generating high-yield influenza vaccine candidates.

Authors:  Jianqiang Ye; Feng Wen; Yifei Xu; Nan Zhao; Liping Long; Hailiang Sun; Jialiang Yang; Jim Cooley; G Todd Pharr; Richard Webby; Xiu-Feng Wan
Journal:  Virology       Date:  2015-04-17       Impact factor: 3.616

5.  Specific inhibition of paramyxovirus and myxovirus replication by oligopeptides with amino acid sequences similar to those at the N-termini of the F1 or HA2 viral polypeptides.

Authors:  C D Richardson; A Scheid; P W Choppin
Journal:  Virology       Date:  1980-08       Impact factor: 3.616

6.  Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells.

Authors:  Seok-Man Ho; Brigham J Hartley; Julia Tcw; Michael Beaumont; Khalifa Stafford; Paul A Slesinger; Kristen J Brennand
Journal:  Methods       Date:  2015-11-25       Impact factor: 3.608

7.  Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Authors:  J B Patterson; T I Cornu; J Redwine; S Dales; H Lewicki; A Holz; D Thomas; M A Billeter; M B Oldstone
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

8.  Mutant fusion proteins with enhanced fusion activity promote measles virus spread in human neuronal cells and brains of suckling hamsters.

Authors:  Shumpei Watanabe; Yuta Shirogane; Satoshi O Suzuki; Satoshi Ikegame; Ritsuko Koga; Yusuke Yanagi
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design.

Authors:  Yushen Du; Li Xin; Yuan Shi; Tian-Hao Zhang; Nicholas C Wu; Lei Dai; Danyang Gong; Gurpreet Brar; Sara Shu; Jiadi Luo; William Reiley; Yen-Wen Tseng; Hongyan Bai; Ting-Ting Wu; Jieru Wang; Yuelong Shu; Ren Sun
Journal:  Science       Date:  2018-01-19       Impact factor: 47.728

Review 10.  Pathological consequences of systemic measles virus infection.

Authors:  Martin Ludlow; Stephen McQuaid; Dan Milner; Rik L de Swart; W Paul Duprex
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

View more
  4 in total

1.  Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.

Authors:  Irene González-Domínguez; Jose Luis Martínez; Stefan Slamanig; Nicholas Lemus; Yonghong Liu; Tsoi Ying Lai; Juan Manuel Carreño; Gagandeep Singh A; Gagandeep Singh B; Michael Schotsaert; Ignacio Mena; Stephen McCroskery; Lynda Coughlan; Florian Krammer; Adolfo García-Sastre; Peter Palese; Weina Sun
Journal:  bioRxiv       Date:  2022-03-22

2.  Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice.

Authors:  Irene González-Domínguez; Jose Luis Martínez; Stefan Slamanig; Nicholas Lemus; Yonghong Liu; Tsoi Ying Lai; Juan Manuel Carreño; Gagandeep Singh; Gagandeep Singh; Michael Schotsaert; Ignacio Mena; Stephen McCroskery; Lynda Coughlan; Florian Krammer; Adolfo García-Sastre; Peter Palese; Weina Sun
Journal:  Microbiol Spectr       Date:  2022-06-06

3.  Zoonotic potential of a novel bat morbillivirus.

Authors:  Benhur Lee; Satoshi Ikegame; Jillian Carmichael; Heather Wells; Robert Furler; Joshua Acklin; Hsin-Ping Chiu; Kasopefoluwa Oguntuyo; Robert Cox; Aum Patel; Shreyas Kowdle; Christian Stevens; Miles Eckley; Shijun Zhan; Jean Lim; Takao Hashiguchi; Edison Luís Durigon; Tony Schountz; Jonathan Epstein; Richard Plemper; Peter Daszak; Simon Anthony
Journal:  Res Sq       Date:  2021-09-29

4.  Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.

Authors:  Akatsuki Saito; Takashi Irie; Rigel Suzuki; Tadashi Maemura; Hesham Nasser; Keiya Uriu; Yusuke Kosugi; Kotaro Shirakawa; Kenji Sadamasu; Izumi Kimura; Jumpei Ito; Jiaqi Wu; Kiyoko Iwatsuki-Horimoto; Mutsumi Ito; Seiya Yamayoshi; Samantha Loeber; Masumi Tsuda; Lei Wang; Seiya Ozono; Erika P Butlertanaka; Yuri L Tanaka; Ryo Shimizu; Kenta Shimizu; Kumiko Yoshimatsu; Ryoko Kawabata; Takemasa Sakaguchi; Kenzo Tokunaga; Isao Yoshida; Hiroyuki Asakura; Mami Nagashima; Yasuhiro Kazuma; Ryosuke Nomura; Yoshihito Horisawa; Kazuhisa Yoshimura; Akifumi Takaori-Kondo; Masaki Imai; Shinya Tanaka; So Nakagawa; Terumasa Ikeda; Takasuke Fukuhara; Yoshihiro Kawaoka; Kei Sato
Journal:  Nature       Date:  2021-11-25       Impact factor: 49.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.